QC
ABBV icon

Quent Capital’s AbbVie ABBV Stock Holding History

Quent Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.96M Sell
9,005
-564
-6% -$125K 0.14% 91
2025
Q4 		$2.19M Buy
9,569
+172
+2% +$39.2K 0.16% 86
2025
Q3 		$2.18M Sell
9,397
-82
-0.9% -$16.7K 0.18% 71
2025
Q2 		$1.76M Buy
9,479
+84
+0.9% +$15.6K 0.17% 73
2025
Q1 		$1.97M Buy
9,395
+507
+6% +$98.6K 0.21% 67
2024
Q4 		$1.58M Buy
8,888
+22
+0.2% +$4.04K 0.16% 69
2024
Q3 		$1.75M Buy
8,866
+99
+1% +$18.5K 0.18% 74
2024
Q2 		$1.5M Buy
8,767
+27
+0.3% +$4.47K 0.17% 74
2024
Q1 		$1.59M Buy
8,740
+283
+3% +$48.8K 0.19% 70
2023
Q4 		$1.31M Buy
8,457
+806
+11% +$118K 0.18% 75
2023
Q3 		$1.14M Sell
7,651
-19
-0.2% -$2.79K 0.18% 72
2023
Q2 		$1.03M Buy
7,670
+45
+0.6% +$6.6K 0.16% 78
2023
Q1 		$1.21M Buy
7,625
+137
+2% +$20.9K 0.21% 64
2022
Q4 		$1.21M Buy
7,488
+1,291
+21% +$198K 0.22% 65
2022
Q3 		$832K Buy
6,197
+933
+18% +$134K 0.17% 77
2022
Q2 		$806K Buy
5,264
+315
+6% +$48.1K 0.17% 74
2022
Q1 		$802K Buy
4,949
+876
+22% +$127K 0.15% 93
2021
Q4 		$552K Buy
+4,073
New +$481K 0.12% 146

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quent Capital's ABBV Position: Q1 2026 in Review

Quent Capital reduced its AbbVie (ABBV) stake by 5.9% in Q1 2026, selling an estimated $125K and leaving 9,005 shares worth $1.96M. The position accounts for 0.14% of the portfolio, ranked #91.

Quent Capital first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.19M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Quent Capital held 9,005 shares of AbbVie worth $1.96M as of Q1 2026.
  • Quent Capital sold 564 AbbVie shares in Q1 2026, an estimated $125K.
  • AbbVie made up 0.14% of Quent Capital's portfolio in Q1 2026, its #91 holding.
  • Quent Capital first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's AbbVie position peaked at $2.19M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.